Abstract
Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. There are few reports of aminoglycoside-resistant Aeromonas spp. We report a soft tissue infection containing multiple pathogens, including a strain of Aeromonas hydrophila resistant to amikacin, tobramycin, and multiple cephalosporins.
Original language | English (US) |
---|---|
Pages (from-to) | 1169-1170 |
Number of pages | 2 |
Journal | Journal of clinical microbiology |
Volume | 49 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2011 |
ASJC Scopus subject areas
- Microbiology (medical)